SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001422849-22-000132
Filing Date
2022-02-11
Accepted
2022-02-11 15:31:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC SCHEDULE 13G SEC13G_Filing.htm SC 13G 16655
  Complete submission text file 0001422849-22-000132.txt   18190
Mailing Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071
Business Address 333 SOUTH HOPE STREET 55TH FLOOR LOS ANGELES CA 90071 213-486-9200
Capital World Investors (Filed by) CIK: 0001422849 (see all company filings)

IRS No.: 951411037 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G

Mailing Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203
Business Address 1222 DEMONBREUN STREET SUITE 2000 NASHVILLE TN 37203 6157247755
Revance Therapeutics, Inc. (Subject) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88023 | Film No.: 22620179
SIC: 2834 Pharmaceutical Preparations